About Cerapedics
Cerapedics is a company based in Westminster (United States) founded in 2006.. Cerapedics has raised $88.46 million across 10 funding rounds from investors including GE Capital, Orbimed and Oxford Finance. The company has 3 employees as of September 30, 2009. Cerapedics offers products and services including i-FACTOR P-15 Peptide Enhanced Bone Graft. Cerapedics operates in a competitive market with competitors including Kerecis, MiMedx Group, Ossio, EpiBone and Biocomposites, among others.
- Headquarter Westminster, United States
- Employees 3 as on 30 Sep, 2009
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cerapedics Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$88.46 M (USD)
in 10 rounds
-
Latest Funding Round
$22 M (USD), Series D
Jul 13, 2018
-
Investors
GE Capital
& 5 more
-
Employee Count
3
as on Sep 30, 2009
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cerapedics
Cerapedics offers a comprehensive portfolio of products and services, including i-FACTOR P-15 Peptide Enhanced Bone Graft. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
FDA-approved product to accelerate bone healing in spine surgery.
Unlock access to complete
Unlock access to complete
Funding Insights of Cerapedics
Cerapedics has successfully raised a total of $88.46M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $22 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series D — $22.0M
-
First Round
First Round
(26 Sep 2007)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2018 | Amount | Series D - Cerapedics | Valuation | KCK MedTech |
|
| Apr, 2017 | Amount | Debt – Conventional - Cerapedics | Valuation |
investors |
|
| Sep, 2016 | Amount | Series D - Cerapedics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cerapedics
Cerapedics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include GE Capital, Orbimed and Oxford Finance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture debt firm focused on the life sciences sector
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cerapedics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cerapedics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cerapedics Comparisons
Competitors of Cerapedics
Cerapedics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kerecis, MiMedx Group, Ossio, EpiBone and Biocomposites, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| domain | founded_year | HQ Location |
Developer of stem cells to regrow damaged bones
|
|
| domain | founded_year | HQ Location |
Synthetic calcium composites are developed for bone repair and regeneration.
|
|
| domain | founded_year | HQ Location |
Implants for bone and cartilage regeneration are developed and provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cerapedics
Frequently Asked Questions about Cerapedics
When was Cerapedics founded?
Cerapedics was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Where is Cerapedics located?
Cerapedics is headquartered in Westminster, United States.
Who is the current CEO of Cerapedics?
Valeska Schroeder is the current CEO of Cerapedics.
Is Cerapedics a funded company?
Cerapedics is a funded company, having raised a total of $88.46M across 10 funding rounds to date. The company's 1st funding round was a Series D of $11M, raised on Sep 26, 2007.
How many employees does Cerapedics have?
As of Sep 30, 2009, the latest employee count at Cerapedics is 3.
What does Cerapedics do?
Cerapedics was founded in 2006 and is headquartered in Westminster, United States. Operations focus on the orthobiologics sector, where proprietary synthetic small peptide technology is developed and commercialized. The iFACTOR Peptide Enhanced Bone Graft is offered as a biologic bone graft that incorporates a small peptide to support natural bone healing. An FDA IDE trial for iFACTOR was completed, meeting all four prespecified primary endpoints.
Who are the top competitors of Cerapedics?
Cerapedics's top competitors include Kerecis, EpiBone and Theradaptive.
What products or services does Cerapedics offer?
Cerapedics offers i-FACTOR P-15 Peptide Enhanced Bone Graft.
Who are Cerapedics's investors?
Cerapedics has 6 investors. Key investors include GE Capital, Orbimed, Oxford Finance, KCK MedTech, and MedImmune Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.